Creative Planning’s Dermira, Inc. DERM Stock Holding History

Creative Planning’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,961	Closed	-$57K	–	4229
2017 Q2	$57K	Buy	+1,961	New	+$59.6K	﹤0.01%	2428
2015 Q4	–	Sell	-10	Closed	–	–	4678
2015 Q3	$0	Buy	+10	New	+$243	﹤0.01%	4388

Other funds holding DERM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Creative Planning's DERM Position: Q3 2017 in Review

Creative Planning sold out of Dermira, Inc. (DERM) in Q3 2017, closing a stake of 1,961 shares — an estimated $57K sold.

Creative Planning first reported a position in DERM in Q3 2015 and held it in 2 quarters. The position peaked at $57K in Q2 2017. 123 funds tracked by Wall St. Rank hold DERM as of Q3 2017.

Creative Planning reported no remaining Dermira, Inc. position as of Q3 2017 after selling out during the quarter.
Creative Planning sold 1,961 Dermira, Inc. shares in Q3 2017, an estimated $57K.
Creative Planning first reported a position in Dermira, Inc. in Q3 2015 and held it in 2 quarters.
Creative Planning's Dermira, Inc. position peaked at $57K in Q2 2017.
123 funds tracked by Wall St. Rank held Dermira, Inc. as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.